Zhang Minna, Yuan Yue, Mao Panyong, Zhuang Yingjie
Medical School of Chinese People's Liberation Army, Beijing 100853, China; Center of Therapeutic Research for Hepatocellular Carcinoma.
Department of Nosocomial Infection Control.
Zhonghua Liu Xing Bing Xue Za Zhi. 2015 Feb;36(2):144-7.
To understand the incidence and death patterns of viral hepatitis in China and provide evidence for the prevention and control of viral hepatitis.
The analysis was conducted on the incidence and death data of viral hepatitis published by National Health and Family Planning Commission during 2004-2013.
The incidences of viral hepatitis in Guizhou,Yunnan, Tibet, Gansu, Qinghai,Ningxia and Xinjiang provinces (autonomous region) were high. The major forms were hepatitis B (80.63/100 000) and hepatitis C (9.68/100 000), accounting for 80.90% and 9.25% of the total reported viral hepatitis cases respectively. The incidences of hepatitis A and unidentified hepatitis decreased and the incidence of hepatitis B, C and E increased during this period. During the 10 years, 10 008 deaths caused by viral hepatitis were reported (1 001 deaths per year). The reported deaths caused by hepatitis A, hepatitis E and unidentified hepatitis decreased during this period. The reported deaths caused by hepatitis B were in a downward trend, but the constituent in total cases remained high. The reported deaths caused by hepatitis C were in an upward trend.
During 2004-2013, the overall incidence of viral hepatitis showed no downward trend in China. The incidence of hepatitis B remained high, and the incidence of hepatitis C showed an obvious upward trend. The overall death rate and case fatality rate of viral hepatitis showed a downward trend, but hepatitis B remained the main cause of viral hepatitis related death, and the death caused by hepatitis C was in increase. Hepatitis B and hepatitis C are the major targets in the prevention and treatment of viral hepatitis in China, and the 7 western provinces (autonomous region) with high incidences are the key regions of the prevention and control.
了解我国病毒性肝炎的发病及死亡情况，为病毒性肝炎的防控提供依据。
对国家卫生和计划生育委员会公布的2004—2013年病毒性肝炎发病与死亡数据进行分析。
贵州、云南、西藏、甘肃、青海、宁夏和新疆等省（自治区）病毒性肝炎发病率较高。主要类型为乙型肝炎（80.63/10万）和丙型肝炎（9.68/10万），分别占报告病毒性肝炎病例总数的80.90%和9.25%。在此期间，甲型肝炎和未分型肝炎发病率下降，乙型、丙型和戊型肝炎发病率上升。10年间，报告病毒性肝炎所致死亡10 008例（年均1 001例）。此期间，报告甲型、戊型肝炎及未分型肝炎所致死亡下降。报告乙型肝炎所致死亡呈下降趋势，但在总病例中的构成比仍高。报告丙型肝炎所致死亡呈上升趋势。
2004—2013年我国病毒性肝炎总体发病率无下降趋势，乙型肝炎发病率仍高，丙型肝炎发病率呈明显上升趋势。病毒性肝炎总体死亡率和病死率呈下降趋势，但乙型肝炎仍是病毒性肝炎相关死亡的主要原因，丙型肝炎所致死亡呈上升趋势。乙型和丙型肝炎是我国病毒性肝炎防治的主要目标疾病，西部7个高发省（自治区）是防控重点地区。
